Search clinical trials for: gastric cancer, DC vaccine, CTL, MG-7 antigen, PD-1 monoclonal antibody
Total 76370 results
-
The Second Hospital of Shandong UniversityShandong Sunstem Biotechnology Co.,Ltd.Unknown
-
National Institute on Drug Abuse (NIDA)TerminatedPlacebo | Daily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, FollowedUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingNasopharyngeal Carcinoma | Gastric Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell CarcinomaChina
-
PfizerTerminatedParkinson's Disease With Motor FluctuationsUnited States
-
Zucara Therapeutics Inc.RecruitingType 1 Diabetes Mellitus With HypoglycemiaUnited States, Canada
-
Guohui LiRecruitingPD-1 | Immune Related Adverse EventsChina
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer | Solid Tumors | Programmed Cell Death-1 (PD1, PD-1) | Programmed Cell Death 1 Ligand 1(PDL1, PD-L1) | Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)Japan
-
University of PadovaUnknown
-
CMG Pharmaceutical Co. LtdCompleted
-
PfizerTerminatedParkinson DiseaseUnited States, Spain, Canada, France, Japan, Germany
-
Shanghai International Medical CenterUnknownAdvanced Solid Tumor | PD-1 Antibody | CAR-T CellsChina
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
Eisai Inc.Merck Sharp & Dohme LLCActive, not recruitingRenal Cell CarcinomaSpain, Canada, Portugal, Korea, Republic of, Taiwan, United States, Netherlands, United Kingdom, Czechia, Italy, Finland, Greece, Romania, Australia, Poland, Russian Federation
-
Lotus PharmaceuticalUnknownThe Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.Taiwan
-
Serum Institute of India Pvt. Ltd.PPDCompleted
-
Ningbo Cancer HospitalUnknownAdvanced Malignancies | PD-1 Antibody | CAR-T CellsChina
-
PfizerWithdrawnBladder CancerPoland, United States
-
Ascletis Pharmaceuticals Co., Ltd.RecruitingHIV Infections | HIV-1-infection | PD-L1 Gene MutationChina
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerUnited States, Australia, France, Germany, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, United Kingdom
-
KLS MartinClinical Study Centers, LLCRecruitingArthrosis | Pseudarthrosis | Intraarticular Fracture | Extraarticular FractureGermany
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
Merck Sharp & Dohme LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Primary Mediastinal B-Cell Lymphoma
-
Beijing Friendship HospitalNot yet recruiting
-
OSE ImmunotherapeuticsRecruitingDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasLymphoma | Solid Advanced TumorFrance, Belgium
-
Sun Yat-sen UniversityRecruitingHepatocellular Carcinoma | PD-1 Inhibitor | Lenvatinib | Hepatic Arterial Infusion ChemotherapyChina
-
Trinity Hypertension & Metabolic Research InstituteCompletedJNC 7 Stage 1 or 2 HypertensionUnited States
-
Ain Shams UniversityCompletedHematologic Pregnancy ComplicationsEgypt
-
Harbour BioMed (Guangzhou) Co. Ltd.RecruitingThyroid OphthalmopathyChina
-
Merck Sharp & Dohme LLCActive, not recruitingHead and Neck NeoplasmsPoland, Canada, Brazil, Belgium, Japan, United States, Argentina, Australia, Austria, Chile, Colombia, France, Germany, Hungary, Ireland, Israel, Korea, Republic of, Portugal, Russian Federation, Spain, Switzerland, Taiwan, Ukraine, United...
-
Harbour BioMed (Guangzhou) Co. Ltd.CompletedMyasthenia GravisChina
-
RenJi HospitalRecruitingRadiotherapy | Muscle Invasive Bladder Cancer | PD-1 | HER2 Expression | Antibody-drug ConjugatesChina
-
Xijing HospitalRecruitingPD-1 | Locally Advanced Gastric AdenocarcinomaChina
-
Merck Sharp & Dohme LLCRecruitingSmall Cell Lung CancerUnited States, Australia, Belgium, Bulgaria, Canada, China, France, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Portugal, Romania, Russian Federation, Serbia, South Africa, Spain, Turkey, Ukraine, United... and more
-
Peking UniversityNot yet recruitingGastroesophageal Junction Cancer | Chemoradiotherapy | PD-1
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern... and other collaboratorsRecruitingNasopharyngeal Carcinoma | Surgery | PD-1China
-
Merck Sharp & Dohme LLCTerminatedNeoplasm MetastasisUnited States, Canada, Israel
-
HK inno.N CorporationCompletedFood Effect Study of CJ-30056 20mg/500mgKorea, Republic of
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Jeil Pharmaceutical Co., Ltd.Completed
-
OhioHealthTerminatedBreast Cancer Stages I Through IIIUnited States
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | G-CSFChina
-
Beijing Friendship HospitalNot yet recruiting
-
Jair Bar, M.D., Ph.D.Merck Sharp & Dohme LLCCompletedNon Small Cell Lung Carcinoma | Stage II | Stage IIsrael
-
Merck Sharp & Dohme LLCCompletedUrothelial Carcinoma Associated 1 RNA, Human
-
Cairo UniversityMohamed, Ahmed A., M.D.; Mohamed Yousry Mohamed; Tamer Fayez Safan; Tamer Mohamed... and other collaboratorsCompleted
-
Centre Leon BerardNETRIS PharmaRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsFrance
-
Jiangsu vcare pharmaceutical technology co., LTDCompletedHealthy Subjects | PK/PDChina